跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
COMPONENT E-C IMPLANTS WITH TYLAN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
COMPONENT E-C IMPLANTS WITH TYLAN
Authorized
STANDARD
COMPONENT E-C IMPLANTS WITH TYLAN
ELANCO CANADA LIMITED
🇨🇦 Health Canada
Approval Date
Feb 5, 2026
Approval ID
0bb5bb084765fb59
Company
ELANCO CANADA LIMITED
Type
Standard
Approval Details
Approval Id
0bb5bb084765fb59
Drug Approval Canada Name
COMPONENT E-C IMPLANTS WITH TYLAN
Product Name
COMPONENT E-C IMPLANTS WITH TYLAN
Status
Marketed
Status Date
2019-06-12
Original Market Date
2016-05-18
Drug Class
Veterinary
Dosage Form
Implant
Route Of Administration
Subcutaneous
Schedule
Prescription
Atc Original
Not Applicable
Aig Number
0347141002
Company Name
ELANCO CANADA LIMITED
Company Address
401 1919 Minnesota Court Mississauga Ontario Canada L5N 0C9
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Feb 5, 2026
Approval ID
0bb5bb084765fb59
Type
Standard
Back to Health Canada Approvals